To evaluate the effect of blood product injected in to the jaw joint for management of jaw disorders
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Patients with temporomandibular joint disorders and refractory to conservative management
- Registration Number
- CTRI/2018/05/013988
- Lead Sponsor
- Dr kranthi kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1. Patients with pain, functional disability, and who have not responded to any of the conservative treatment were included in the study.
2. Patients of category ASA I & II.
Exclusion Criteria
1.Patients on long term steroid therapy.
2.Patients on anticoagulants.
3.Patients with connective tissue disease disorders involving the joints, mentally
challenged patients.
4.Patients of category ASA III & IV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptomatic pain reliefTimepoint: 1st week, 1st month, 3rd month and 6th month
- Secondary Outcome Measures
Name Time Method Mouth opening and joint soundsTimepoint: patient is evaluated at 1st week, 1st month, 3rd month and 6th month